Product How it works Pricing Blog FAQ About Contact
Tarsus Pharmaceuticals

Tarsus Pharmaceuticals (NASDAQ: TARS) revenue

Tarsus Pharmaceuticals reported revenue of $451.4m for fiscal 2025, 146.7% more than in fiscal 2024 ($183.0m).

Tarsus Pharmaceuticals has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 6 fiscal years on record. The biggest drop was in fiscal 2022, −54.7%.

Revenue, in millions of US dollars0.0202057.0202125.8202217.42023183.02024451.42025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$451.4m+146.7%−$71.0m−15.7%
2024$183.0m+948.6%−$120.6m−65.9%
2023$17.4m−32.4%−$143.2m−820.5%
2022$25.8m−54.7%−$62.7m−242.9%
2021$57.0m—−$12.2m−21.3%
2020$0.0m—−$27.0m—

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Tarsus Pharmaceuticals revenue compared with its sector

By revenue for its latest fiscal year, Tarsus Pharmaceuticals ranks 198th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Tarsus Pharmaceuticals, 146.7%.

RankCompanyRevenueRevenue growth
196thPhreesia$480.6m14.5%
197thZai Lab$460.2m15.3%
198thTarsus Pharmaceuticals$451.4m146.7%
199thArtivion$441.3m13.6%
200thGeneDx$427.5m40.0%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Tarsus Pharmaceuticals

How much revenue did Tarsus Pharmaceuticals make in fiscal 2025?
Tarsus Pharmaceuticals reported revenue of $451.4m for fiscal 2025, compared with $183.0m in fiscal 2024.
What was the best year for revenue at Tarsus Pharmaceuticals?
Of its last 6 fiscal years, fiscal 2025, with $451.4m.
Where does Tarsus Pharmaceuticals rank in its sector by revenue?
It ranks 198th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Tarsus Pharmaceuticals come from?
From the annual report (Form 10-K) that Tarsus Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Tarsus Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Tarsus Pharmaceuticals: the Tarsus Pharmaceuticals page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.